Aktionärsstruktur der AstraZeneca PLC
Portrait der AstraZeneca Aktie
Das Unternehmen AstraZeneca PLC aus Großbritannien ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Biotechnologie & Pharmazeutika, Pharma tätig.
ASTRAZENECA PHARMA INDIA LTD ist ein Tochterunternehmen von AstraZeneca.
Das Unternehmen AstraZeneca PLC ist in mehr als 74 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares STOXX Europe 600 Health Care UCITS ETF (DE) gewichtet AstraZeneca mit 9,81% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle AstraZeneca Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen AstraZeneca PLC am höchsten gewichtet ist Insgesamt in 74 ETFs enthalten
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu AstraZeneca?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
718 News & Informationen zur AstraZeneca Aktie
AstraZeneca (AZN) Rare Disorder Drug Koselugo Gets EU Nod
AstraZeneca's (AZN) Koselugo becomes the first medicine approved in Europe for neurofibromatosis type 1 plexiform neurofibromas.
Analysis: From game-changer to back-up: J&J's COVID vaccine struggles in Europe By Reuters
Analysis: From game-changer to back-up: J&J's COVID vaccine struggles in Europe
AstraZeneca : Orpathys approved in China for patients with lung cancer and MET gene alterations
PUBLISHED23 June 2021
23 June 2021 07:00 BST
First-in-class… | June 23, 2021
Sydney’s delta variant outbreak triggers travel clamps, mandatory masks
From Wednesday afternoon, households will be limited to hosting five guests, while masks will be mandatory in indoor venues including workplaces and shops .Residents in eastern and inner-west areas of Sydney won’t be allowed to travel outside the city for non-essential reasons for at least a week
COVID-19: B.C. intake of AstraZeneca vaccine on decline following NACI recommendations
Fewer British Columbians are opting to stick with the AstraZeneca plc COVID-19 vaccine for their second dose following recommendations last week from the National Advisory Council on Immunization (NACI).
AstraZeneca vaccine effective against COVID-19 variants identified in India By Reuters
AstraZeneca vaccine effective against COVID-19 variants identified in India
HUTCHMED announces savolitinib approved in China for patients with lung cancer with MET exon 14 skipping alterations
– First selective MET inhibitor approval in China in this setting – – First regulatory approval for the oral, potent and selective MET tyrosine… | June 22, 2021
These Tech Stocks Will Benefit As The Fed’s Advances Rate Hike Timeline
Our theme of Value Tech Stocks is up by about 13% year-to-date, compared to the Nasdaq-100 which is up by just about 11%. Although this doesn’t really count as meaningful outperformance, we see multiple catalysts for the theme in the medium to long term. Firstly, the Federal Reserve signaled that…
AstraZeneca : SPRINT Phase II trial showed Koselugo reduced tumour volume, reducing pain and improving quality of life (Form 6-K)
SPRINT Phase II trial showed Koselugo reduced tumour volume, reducing pain and improving quality of life
AstraZenecaand MSD's Koselugo has been granted conditional approval in… | June 22, 2021
AstraZeneca : EU Oks Koselugo For Children With Neurofibromatosis Type 1 & Plexiform Neurofibromas
(RTTNews) – AstraZeneca (AZN.L, AZN) and Merck & Co.'s Koselugo or selumetinib has received conditional approval in the European Union for the tre…
Dual-antibody drugs effective against COVID-19 variants in animal study By Reuters
Dual-antibody drugs effective against COVID-19 variants in animal study
Here is What Hedge Funds Think About Philip Morris International Inc. (PM)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
Biden Details Latest Vaccine Donations, Delays June Target
(Bloomberg) — President Joe Biden is delaying a target date for overseas shipments of 80 million doses of coronavirus vaccines donated by the U.S., with…
Dave Johnson Joins Biosplice Therapeutics Board of Directors
SAN DIEGO, June 21, 2021 (GLOBE NEWSWIRE) — Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics…
GSK to boost spending power of pharma business post break-up By Reuters
GSK to boost spending power of pharma business post break-up
GSK to boost spending power of pharma business post break-up
GlaxoSmithKline (GSK.L) will lay out plans to boost the spending power of its research-focused pharmaceuticals business at an investor day on Wednesday, as analysts call on the British drugmaker to boost drug development prospects with takeovers or alliances.
U.S. Economy Is Bouncing Back From Covid-19. Now Foreign Investors Are Rushing In.
The extraordinary recovery of the U.S. economy is set to make the country the world’s top destination for overseas investment this year and next, with foreign businesses drawn by the prospect of a rapid and sustained rebound in consumer spending.
Albireo Announces Expanded Phase 3 Data on Bylvay™ (odevixibat) and A3907 at Upcoming EASL International Liver Congress
– Bylvay demonstrates rapid reductions in serum bile acids and long-term improvements in growth, sleep, and hepatic parameters – – Bylvay patient responder data show… | June 21, 2021
AstraZeneca (AZN) Gets Court Order to Supply COVID-19 Jabs in EU
A court in Brussels orders AstraZeneca (AZN) to supply 80 million doses of its COVID-19 vaccine to Europe by Sep 27, 2021. The European Commission had requested for 300 million doses by end of September.
Turbocharged U.S. Economy Attracts Foreign Investors
The extraordinary recovery of the U.S. economy is set to make the country the world’s top destination for overseas investment this year and next, with foreign businesses drawn by the prospect of a rapid and sustained rebound in consumer spending.
Vaccitech chief confident of beating mRNA in cancer treatment
Group behind AstraZeneca jab believes it has better chance of success in tackling tumours
Vaccine Manufacturing Issues Force Moderna to Cut Supplies to Canada, U.K.
The problems involve Moderna’s Covid-19 vaccine supply chain for countries other than the U.S., the company said.
Canada secures 8m more Pfizer doses amid Moderna uncertainty
Canada is ramping up orders of COVID-19 vaccine doses from Pfizer Inc. (NYSE:PFE) amid ongoing delivery delays from Moderna Inc. (NYSE:MRNA).
Pfizer, Moderna Gain on Possibility Covid Vaccines Become Annual Need By Investing.com
Pfizer, Moderna Gain on Possibility Covid Vaccines Become Annual Need
The FTSE 100 passes 7,000 points! Here’s why I think it can go higher still in 2021
A mix of positive sentiment from the economy and long-term foreign investment means the FTSE 100 is performing well, writes Jonathan Smith.
Morgan Stanley Falls Premarket; DraftKings, Alcoa Rise By Investing.com
Morgan Stanley Falls Premarket; DraftKings, Alcoa Rise
Australia reports first death from blood clots 'likely' linked to AstraZeneca vaccine By Reuters
Australia reports first death from blood clots 'likely' linked to AstraZeneca vaccine
Countries seek more Moderna, Pfizer/BioNTech shots as concerns mount over rival vaccines
Countries in Europe and Asia, as well as South Africa, are limiting or halting use of AstraZeneca's shot over safety concerns. Rollout of J&J's one-shot vaccine was paused in the United States and Europe this week over a handful of cases of very rare but dangerous blood clots in the brain, much like AstraZeneca's safety issue.
Olympics: Australia weighing whether to let athletes jump vaccine queue By Reuters
Olympics: Australia weighing whether to let athletes jump vaccine queue
Fauci says he believes J&J vaccine will 'get back on track soon' By Reuters
Fauci says he believes J&J vaccine will 'get back on track soon'
Variants fuel covid-19 surge, but scientists voice optimism for vaccines
As coronavirus strains spread, experts say public-health measures remain critical to curbing infections
Will Novavax Stock Benefit From Johnson & Johnson’s Covid Vaccine Woes?
Novavax (NASDAQ: NVAX) stock rallied by over 10% after the U.S. Food and Drug Administration and the U.S. Centers for Disease Control paused the rollout of Johnson & Johnson’s Covid-19 vaccine in the U.S. following some rare, yet severe incidents of blood clotting.
Will U.S. Retail Sales Shake Up Euro?
Forex Analysis by MarketPulse (Kenny Fisher) covering: EUR/USD, US Dollar Index Futures, AstraZeneca PLC ADR. Read MarketPulse (Kenny Fisher)'s latest article on Investing.com
Yields Nudge Up
Market Overview Analysis by Stephen Innes covering: EUR/USD, USD/CAD, XAU/USD, Johnson & Johnson. Read Stephen Innes's latest article on Investing.com
WTO chief lays out global action to increase vaccine access By Reuters
WTO chief lays out global action to increase vaccine access
Evening Update: AstraZeneca’s COVID-19 vaccine to remain on the Canadian market; Ottawa aims to make 90,000 temporary workers and graduated students permanent residents
Also in the news today, Bernard Madoff, who was convicted for running the largest known Ponzi scheme in history, has died
3 Stock Picks With High Returns on Equity
3 Stock Picks With High Returns on Equity, Stocks: AZN,PGNY,CNNE, release date:Apr 14, 2021
J&J covid-19 vaccine pause spotlights science of rare clotting disorder
Scientists are probing cause of blood clots that affected six recipients of Johnson & Johnson’s viral-vector vaccine
2 Cheap Dividend Stocks You Can Buy Right Now
Their payouts are far better than what you would get with the average stock on the S&P 500.
Upbeat Earnings From Financial Giants May Generate Early Buying Interest
The major U.S. index futures are currently pointing to a modestly higher open on Wednesday, with stocks likely to extend the upward move seen in the previous session.